Skip to main content

An Approach for Identification of Novel Drug Targets in Streptococcus pyogenes SF370 Through Pathway Analysis

Abstract

Streptococcus pyogenes is one of the most important pathogens as it is involved in various infections affecting upper respiratory tract and skin. Due to the emergence of multidrug resistance and cross-resistance, S. Pyogenes is becoming more pathogenic and dangerous. In the present study, an in silico comparative analysis of total 65 metabolic pathways of the host (Homo sapiens) and the pathogen was performed. Initially, 486 paralogous enzymes were identified so that they can be removed from possible drug target list. The 105 enzymes of the biochemical pathways of S. pyogenes from the KEGG metabolic pathway database were compared with the proteins from the Homo sapiens by performing a BLASTP search against the non-redundant database restricted to the Homo sapiens subset. Out of these, 83 enzymes were identified as non-human homologous while 30 enzymes of inadequate amino acid length were removed for further processing. Essential enzymes were finally mined from remaining 53 enzymes. Finally, 28 essential enzymes were identified in S. pyogenes SF370 (serotype M1). In subcellular localization study, 18 enzymes were predicted with cytoplasmic localization and ten enzymes with the membrane localization. These ten enzymes with putative membrane localization should be of particular interest. Acyl-carrier-protein S-malonyltransferase, DNA polymerase III subunit beta and dihydropteroate synthase are novel drug targets and thus can be used to design potential inhibitors against S. pyogenes infection. 3D structure of dihydropteroate synthase was modeled and validated that can be used for virtual screening and interaction study of potential inhibitors with the target enzyme.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. Suvrov AN, Ferretti JJ (1996) Physical and genetic map of an M type 1 strain of Streptococcus pyogenes. J Bacteriol 178:5546–5549

    Article  Google Scholar 

  2. Bisno AL, Brito MO, Collins CM (2003) Molecular basis of group A streptococcal virulence. Lancet Infect Dis 3:191–200

    Article  CAS  PubMed  Google Scholar 

  3. Fiedler T, Köller T, Kreikemeyer B (2015) Streptococcus pyogenes biofilms formation, biology, and clinical relevance. Front Cell Infect Microbiol. doi:10.3389/fcimb.2015.00015

    PubMed  PubMed Central  Google Scholar 

  4. Fan J, Dong L, Chen Z, Bei D (2014) Clinical characteristics and antimicrobial resistance of invasive group A β-hemolytic streptococcus infection in children. Zhonghua Er Ke Za Zhi 52:46–50

    PubMed  Google Scholar 

  5. Ferretti JJ, McShan WM, Ajdic D, Savic DJ, Savic G, Lyon K, Primeaux C et al (2001) Complete genome sequence of an M1 strain of Streptococcus pyogenes. Proc Natl Acad Sci USA 98:4658–4663

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Kanehisa M, Goto S, Kawashima S, Nakaya A (2002) The KEGG databases at genome net. Nucl Acids Res 30:42–46

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ (1997) Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res 25:3389–3402

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Singh S, Singh G, Sagar N, Yadav PK, Jain PA, Gautam B, Wadhwa G (2012) Insight into Trichomonas vaginalis genome evolution through metabolic pathways comparison. Bioinformation 8:189–195

    Article  PubMed  PubMed Central  Google Scholar 

  9. Yu CS, Chen YC, Lu CH, Hwang JK (2006) Prediction of protein subcellular localization. Proteins Struct Funct Bioinform 64:643–651

    Article  CAS  Google Scholar 

  10. Yu CS, Lin CJ, Hwang JK (2004) Predicting subcellular localization of proteins for Gram-negative bacteria by support vector machines based on n-peptide compositions. Protein Sci 13:1402–1406

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, Pieper U, Sali A (2007) Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci. doi:10.1002/0471140864.ps0209s50

    PubMed  Google Scholar 

  12. Lüthy R, Bowie JU, Eisenberg D (1992) Assessment of protein models with three-dimensional profiles. Nature 356:83–85

    Article  PubMed  Google Scholar 

  13. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM (1996) AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR 8:477–486

    Article  CAS  PubMed  Google Scholar 

  14. Colovos C, Yeates TO (1993) Verification of protein structures: patterns of nonbonded atomic interactions. Protein Sci 2:1511–1519

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35(Web Server issue):W407–W410

    Article  PubMed  PubMed Central  Google Scholar 

  16. Singh S, Singh G, Gautam B, Jain PA, Yadav PK (2011) In silico metabolic pathway analysis of Trichomonas vaginalis for potential drug targets. Elixir Biol Phys 32:1991–1994

    Google Scholar 

  17. Zhang L, Liu W, Xiao J, Hu T, Chen J, Chen K, Jiang H, Shen X (2007) Malonyl-CoA: acyl carrier protein transacylase from Helicobacter pylori: crystal structure and its interaction with acyl carrier protein. Protein Sci 16:1184–1192

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Gui WJ, Lin SQ, Chen YY, Zhang XE, Bi LJ, Jiang T (2011) Crystal structure of DNA polymerase III β sliding clamp from Mycobacterium tuberculosis. Biochem Biophys Res Commun 405:272–277

    Article  CAS  PubMed  Google Scholar 

  19. Subbayya IN, Ray SS, Balaram P, Balaram H (1997) Metabolic enzymes as potential drug targets in Plasmodium falciparum. Indian J Med Res 106:79–94

    CAS  PubMed  Google Scholar 

  20. Dias MV, Ely F, Palma MS, de Azevedo WF, LA Jr Basso, Santos DS (2007) Chorismate synthase: an attractive target for drug development against orphan diseases. Curr Drug Targets 8:437–444

    Article  CAS  PubMed  Google Scholar 

  21. Vidya N, Vadivukkarasi B, Manivannan G, Anbarasu K (2008) Molecular modeling and docking studies of glutamate racemase in Vibrio vulnificus CMCP6. In Silico Biol 8:471–483

    CAS  PubMed  Google Scholar 

  22. Zíková A, Schnaufer A, Dalley RA, Panigrahi AK, Stuart KD (2009) The F(0)F(1)-ATP synthase complex contains novel subunits and is essential for procyclic Trypanosoma brucei. PLoS Pathog. doi:10.1371/journal.ppat.1000436

    PubMed  PubMed Central  Google Scholar 

  23. Iliades P, Meshnick SR, Macreadie IG (2004) Dihydropteroate synthase mutations in Pneumocystis jiroveci can affect sulfamethoxazole resistance in a Saccharomyces cerevisiae model. Antimicrob Agents Chemother 48:2617–2623

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Olabisi OC, Prasit P (2011) Current understanding of de novo synthesis of bacterial lipid carrier (undecaprenyl phosphate): more enzymes to be discovered. Afr J Microbiol Res 5:2555–2565

    Article  Google Scholar 

  25. Achari A, Somers DO, Champness JN, Bryant PK, Rosemond J, Stammers DK (1997) Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase. Nat Struct Biol 4:490–497

    Article  CAS  PubMed  Google Scholar 

  26. Singh DB, Gupta MK, Kesharwani RK, Sagar M, Dwivedi S, Misra K (2014) Drug targets and therapies for Alzheimer’s disease. Trans Neurol 5:203–217

    Google Scholar 

  27. Singh DB, Gupta MK, Singh DV, Singh SK, Misra K (2013) Docking and in silico ADMET studies of noraristeromycin, curcumin and its derivatives with plasmodium falciparum SAH hydrolase: a molecular drug target against malaria. Interdiscip Sci 5:1–12

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dev Bukhsh Singh.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 16 kb)

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, S., Singh, D.B., Singh, A. et al. An Approach for Identification of Novel Drug Targets in Streptococcus pyogenes SF370 Through Pathway Analysis. Interdiscip Sci Comput Life Sci 8, 388–394 (2016). https://doi.org/10.1007/s12539-015-0139-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12539-015-0139-2

Keywords